(Q41352575)

29 September 2017

Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro (English)

1 reference

29 September 2017

2

Fauci AS

1 reference

29 September 2017

Lê thi Bich-Thuy

1

1 reference

PubMed ID

2933262

29 September 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

European Journal of Immunology

29 September 2017

1 reference

29 September 2017

15

1 reference

29 September 2017

1075-1079

1 reference

29 September 2017

11

1 reference

Regulation of B-Cell Growth and Differentiation by Soluble Factors

29 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

B Cell Growth and Differentiation Factors and Mechanism of B Cell Activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Expression of interleukin 2 receptors on activated human B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Expression of Tac antigen on activated normal human B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Heterogeneity of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

H-2-unrestricted polyclonal maturation without replication of small B cells induced by antigen-activated T cell help factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Antigen-specific helper T-cell clone supernatant is sufficient to induce both polyclonal proliferation and differentiation of small resting B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830151102

7 January 2021

Identifiers

DOI

10.1002/EJI.1830151102

1 reference

29 September 2017

1 reference

PubMed ID

2933262